找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Combination Therapy in Hypertension; Joel M. Neutel Book 2011 Springer Healthcare 2011 Combination Therapy.Hypertension.Polypharmacy.blood

[复制链接]
查看: 6888|回复: 43
发表于 2025-3-21 18:36:48 | 显示全部楼层 |阅读模式
书目名称Combination Therapy in Hypertension
编辑Joel M. Neutel
视频videohttp://file.papertrans.cn/230/229860/229860.mp4
概述Dr Neutel is an innovative and leading specialist in clinical hypertension and a prominent advocate of the need for combination therapy in its treatment.This concise pocket book provides concise pract
图书封面Titlebook: Combination Therapy in Hypertension;  Joel M. Neutel Book 2011 Springer Healthcare 2011 Combination Therapy.Hypertension.Polypharmacy.blood
描述For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be administered to be effective. Consequently, there have been increasing calls of the necessity for a much more combined approach in the treatment of hypertension. Adding to this, Combination Therapy in Hypertension will cover current control rates of blood pressure worldwide, the benefits of monotherapy and combination therapy, examine the effectiveness, risk of adverse effects, compliance, and cost of the
出版日期Book 2011
关键词Combination Therapy; Hypertension; Polypharmacy; blood pressure; cardiovascular; patients; pharmacotherapy
版次1
doihttps://doi.org/10.1007/978-1-908517-28-9
isbn_softcover978-1-908517-25-8
isbn_ebook978-1-908517-28-9
copyrightSpringer Healthcare 2011
The information of publication is updating

书目名称Combination Therapy in Hypertension影响因子(影响力)




书目名称Combination Therapy in Hypertension影响因子(影响力)学科排名




书目名称Combination Therapy in Hypertension网络公开度




书目名称Combination Therapy in Hypertension网络公开度学科排名




书目名称Combination Therapy in Hypertension被引频次




书目名称Combination Therapy in Hypertension被引频次学科排名




书目名称Combination Therapy in Hypertension年度引用




书目名称Combination Therapy in Hypertension年度引用学科排名




书目名称Combination Therapy in Hypertension读者反馈




书目名称Combination Therapy in Hypertension读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:29:41 | 显示全部楼层
发表于 2025-3-22 02:22:41 | 显示全部楼层
发表于 2025-3-22 05:16:00 | 显示全部楼层
Sir Philip Sidney, Cultural Icon studies indicate that administration of low-dose combination therapy enables adequate blood pressure control to be achieved in all subgroups of hypertensive patients, including the elderly, African–Americans, Caucasians, and patients with diabetes or metabolic syndrome.
发表于 2025-3-22 08:52:59 | 显示全部楼层
Sir Philip Sidney, Cultural Iconbination therapy may result in greater decreases in systolic blood pressure, a higher rate of control of blood pressure, and a better adverse event profile than do component monotherapies at the same or higher doses.
发表于 2025-3-22 15:41:58 | 显示全部楼层
The Crisis in Church and State,percentage of controlled patients has decreased. Also, significantly, the lower target for blood pressure has created a greater challenge for physicians, who were already having difficulty achieving the 140/90 mmHg goal in their patients.
发表于 2025-3-22 17:33:41 | 显示全部楼层
Advantages of Combination Therapy Compared with Monotherapy,plementary antihypertensive drugs in combination is always associated with greater efficacy than uptitration of an individual antihypertensive agent and provides an improved adverse event profile compared with monotherapy.
发表于 2025-3-22 22:49:09 | 显示全部楼层
Use of Combination Therapy in Special Populations, studies indicate that administration of low-dose combination therapy enables adequate blood pressure control to be achieved in all subgroups of hypertensive patients, including the elderly, African–Americans, Caucasians, and patients with diabetes or metabolic syndrome.
发表于 2025-3-23 04:33:04 | 显示全部楼层
发表于 2025-3-23 09:04:25 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-26 01:08
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表